XML 131 R103.htm IDEA: XBRL DOCUMENT v3.24.3
Income Taxes - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Tax Credit Carryforward [Line Items]    
Valuation allowance, deferred tax asset, increase (decrease), amount $ 60,700,000 $ 13,000,000.0
Unrecognized tax benefits that would impact effective tax rate 2,600,000 1,100,000
Domestic Tax Authority    
Tax Credit Carryforward [Line Items]    
Income tax expense (benefit) 0 0
Operating loss carryforwards 277,900,000 110,500,000
Domestic Tax Authority | Research Tax Credit Carryforward    
Tax Credit Carryforward [Line Items]    
Tax credit carryforward, amount 7,500,000 2,900,000
Domestic Tax Authority | Federal Orphan Drug Tax Credit Carryforward    
Tax Credit Carryforward [Line Items]    
Tax credit carryforward, amount 2,200,000  
Domestic Tax Authority | Subject To Expiration    
Tax Credit Carryforward [Line Items]    
Operating loss carryforwards 2,300,000  
Domestic Tax Authority | Carried Forward Indefinitely    
Tax Credit Carryforward [Line Items]    
Operating loss carryforwards 275,600,000  
State and Local Jurisdiction    
Tax Credit Carryforward [Line Items]    
Income tax expense (benefit) 0 0
Operating loss carryforwards 35,100,000 $ 36,000,000.0
State and Local Jurisdiction | Research Tax Credit Carryforward    
Tax Credit Carryforward [Line Items]    
Tax credit carryforward, amount 100,000  
State and Local Jurisdiction | Subject To Expiration    
Tax Credit Carryforward [Line Items]    
Operating loss carryforwards 33,400,000  
State and Local Jurisdiction | Carried Forward Indefinitely    
Tax Credit Carryforward [Line Items]    
Operating loss carryforwards $ 1,700,000